Are you aligned to the changes that could impact exports to the US?
Navigating today's global trade environment is challenging for companies involved in exporting products abroad. Compliance with existing regulations and laws is one of the top challenges exporters face, and when combined with the likelihood of increased regulatory controls, the demands are significant.
This is particularly the case in the global food, pharmaceutical and medical device industries. Public opinion has also shifted to the side of caution – as a widespread anxiety has developed around products manufactured abroad.
This lack of confidence in both products and the suppliers that produce them is reflected through foreign regulatory and border control agencies relying heavily on targeting systems and data integration to monitor global trade networks.
In the United States, lawmakers, regulators, consumers and the media are more focused nowadays on food and drug safety than ever before. Exporters of food
and drug products that are targeted at the U.S. market must meet new regulatory compliance rules contained within two relatively new laws that expand the authority of the U.S. Food and Drug Administration (FDA): the Food Safety Modernization Act (FSMA) and the Food and Drug Administration Safety and Innovation Act (FDASIA).
Exporters are expected and often required to be fully transparent with their company information and compliant with all regulations and laws if they are to maintain the flow of goods abroad. In addition, due to the abundance of competition, exporters need to go beyond maintaining their global markets and expand into new markets. As laws and regulations continue to change and become more stringent, it is imperative for exporter to have its business verified by a trusted third-party organization, and be willingly transparent and accountable to regulatory agencies.
Dun & Bradstreet’s D-U-N-S® Verified Solution can help exporters meet existing and anticipated requirements from global regulators through a focus on transparency and accountability, as well as reach new markets as a member of a global supplier registry. For example, the U.S. Food and Drug Administration (FDA) has been utilizing D&B's D-U-N-S® Verified, an onsite verification service, to verify facility registration information that has been previously provided to FDA.
FDA Drug Facility
Dun & Bradstreet Verification
FDA Medical Device Onsite
Registration and Listing Verifications
Benefits of D-U-N-S® Verified Solution
Based on our experience in working with some 250,000 customers around the world, Dun & Bradstreet has introduced the D-U-N-S® Verified Solution to help exporters meet existing and anticipated requirements from global regulators / importers by focusing on transparency and accountability, and to help the exporters reach new markets as a member of a global supplier registry.
Benefits to an exporter include:
Increased transparency of corporate functions and information aiding in compliance of laws and regulations
Improved competitive advantage through an exclusive footprint on a global registry
Increased trust from your existing suppliers due to transparency and visibility
Improved protection for the brand
The Dun & Bradstreet Advantage
Specifically, Dun & Bradstreet can provide
Third party verification through a D-U-N-S® Verified Report
which can aid in navigating the regulatory environment with a detailed report on key company information
A detailed profile on the D-U-N-S® Verified Global Registry
which allows importers an exclusive list of suppliers who and have been verified and are transparent in their business functions